Biocartis Raises EUR10 Million in Series A Financing Round (redOrbit)
LAUSANNE, Switzerland, October 15 /PRNewswire/ — Biocartis SA, a diagnostics company focused on fast and low-cost, integrated molecular and immunodiagnostics based on its proprietary micro-technology platform, today announced the successful closing of a Series A equity financing round.
(more…)